Biomerica, Inc.
BMRA · NASDAQ
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $2 |
| % Growth | 84.2% | -33.1% | -31.6% | – |
| Cost of Goods Sold | $1 | $1 | $1 | $1 |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | 30.7% | -32.6% | 1.7% | 26.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2 | $1 | $1 | $1 |
| Operating Income | -$1 | -$2 | -$1 | -$1 |
| % Margin | -81% | -208.8% | -108.1% | -60.7% |
| Other Income/Exp. Net | $1 | $0 | $0 | $0 |
| Pre-Tax Income | $0 | -$2 | -$1 | -$1 |
| Tax Expense | $0 | $0 | -$0 | -$0 |
| Net Income | $0 | -$2 | -$1 | -$1 |
| % Margin | 0.1% | -206.1% | -103.9% | -58.1% |
| EPS | 0.003 | -0.16 | -0.068 | -0.056 |
| % Growth | 101.9% | -135.6% | -22.3% | – |
| EPS Diluted | 0.003 | -0.16 | -0.068 | -0.056 |
| Weighted Avg Shares Out | 3 | 10 | 17 | 17 |
| Weighted Avg Shares Out Dil | 3 | 10 | 17 | 17 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | -$1 | -$1 | -$1 |
| % Margin | 7.8% | -194.9% | -99.3% | -60.7% |